Company intelligence / Profile preview

Lamarck Diagnostics

Ownership: Private
Development stage: Preclinical

Overview

Lamarck Diagnostics develops an implantable micro-monitoring diagnostic device that collects real-time biomarker data indicative of cardiovascular disease risks. This data is transmitted to a mobile application platform where it is analyzed using genetics-assisted, AI-driven healthcare management tools. The goal is to help predict and prevent future cardiovascular events for patients suffering from chronic and acute heart conditions.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health platformGenetic testing
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Lamarck Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lamarck Diagnostics.

Explore the full profile